| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |